Vir Biotechnology Inc. VIR shares are up during Tuesday’s premarket session following a significant strategic collaboration ...
Vir Biotechnology Inc. VIR reported better-than-expected fourth-quarter earnings, anounced a significant strategic ...
Astellas Pharma Inc. and Vir Biotechnology, Inc. have entered into a global strategic collaboration to advance VIR-5500, an ...
Experts discuss biotechnology's role in advancing personalized medicine at a VIT webinar, highlighting career opportunities ...
The deal builds on a 2022 collaboration between Arcellx and Kite, a Gilead company, and eliminates profit-sharing and milestone structures, consolidating economics under Gilead as it deepens its ...
Cambridge’s Kendall Square bills itself as “the most innovative square mile on the planet” — but it’s possible that less of that innovation is happening in Cambridge as life science firms outsource ...
Siren Biotechnology, pioneers of Universal AAV Immuno-Gene Therapy for cancer, today announced that the U.S. Food and Drug ...
Carnegie Mellon University and the University of Pittsburgh offered rare looks Thursday into two cutting-edge research ...
The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine, as global R&D investment approaches $360 billion ...
The consensus estimate for Q4 2025 revenue is $23.18 million, and the earnings are expected to come in at -$0.41 per share. The full year 2025's revenue is expected to be $19.22 million, and the ...
Dallas Entrepreneur Launches $1,000 Andrew Hillman Biotech Grant for Undergraduates DALLAS, TX, UNITED STATES, February ...
The European Directory of Biotechnology Companies offers key market opportunities by providing access to 2,000 biotech companies and 5,000 executives. It assists in pinpointing decision-makers, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results